Every Form 4 that Cerence Inc. (CRNC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CRNC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CRNC filings page.
On October 9, 2026, Brian M. Krzanich, Cerence Inc.'s Chief Executive Officer, reported a sale of 131,715 common shares at $8.26 per share. The shares were required to be sold to cover tax withholding obligations connected with RSU vesting under the issuer's equity-plan election; the sale was not discretionary. His direct holdings after the sale were 1,568,673 shares.
Cerence Inc. CFO Antonio Rodriquez reported selling 76,614 common shares at $8.00 per share on October 7, 2026. The sale was required to cover tax withholding obligations related to RSU vesting under the issuer’s sell-to-cover election and was not discretionary. He also reported purchasing 2,000 shares at $7.02 per share through the Employee Stock Purchase Plan on February 15, 2026. No Rule 10b5-1 plan is reported.
Cerence Inc. Chief Executive Officer Brian M. Krzanich reported selling 21,703 shares of common stock on October 7, 2026, at $8.00 per share. The sale covered tax withholding obligations connected with RSU vesting and was required under the issuer’s sell-to-cover election; it was not a discretionary trade. Krzanich directly held 1,700,388 shares after the sale. No Rule 10b5-1 plan is reported.
Cerence Inc. (CRNC) EVP, Chief Revenue Officer Christian Mentz sold 48,923 shares of common stock on October 7, 2026, at $8 per share. The shares were sold to cover tax withholding obligations tied to RSU vesting; Cerence’s equity-plan election mandated the transaction, which was not discretionary. Mentz directly held 244,551 shares after the sale.
Jennifer Salinas, Cerence Inc.’s EVP Chief Admin Officer, sold 66,153 shares of common stock at $8.00 per share on October 7, 2026. Reported direct holdings after the sale were 627,876 shares. The sale covered tax withholding obligations connected with RSU vesting and was required under Cerence’s election under its equity incentive plans; it was not a discretionary trade. No Rule 10b5-1 plan is reported.
At Cerence Inc. (CRNC), EVP Product & Technology Nils Schanz sold 52,439 shares of common stock at $8 per share on October 7, 2026, and held 290,243 shares directly after the transaction. The sale covered tax withholding obligations tied to RSU vesting and was required under the issuer’s equity incentive plans, rather than a discretionary trade. No Rule 10b5-1 plan is reported.
Cerence Inc. executive Jennifer Salinas, EVP Chief Admin Officer, reported a sale of 25,998 shares of common stock on 2026-08-10 in an open-market or private transaction. The shares were sold at a weighted average price of $8.8279 per share, with trade prices ranging from $8.675 to $8.965. Following this transaction, she directly holds 694,029 shares of Cerence common stock.
Matus Kristi Ann reported acquisition or exercise transactions in a Form 4 filing for CRNC. The filing lists transactions totaling 12,968 shares at a weighted average price of $0.01 per share. Following the reported transactions, holdings were 54,737 shares.
Cerence Inc. director Marianne Budnik received a new equity award in the form of restricted stock units (RSUs). On 02/12/2026, she acquired 12,968 shares of common stock at a grant price of $0.01 per share, increasing her directly held stake to 60,166 shares.
The RSUs will vest on the earlier of the first anniversary of the grant date or the day immediately before Cerence's next fiscal year Annual General Meeting, aligning the award with both time-based service and the company’s annual shareholder meeting cycle.
Cerence Inc. director Douglas Lee Davis acquired 12,968 shares of common stock as a restricted stock unit award on February 12, 2026 at a price of $0.01 per share. Following this grant, he directly beneficially owns 39,544 common shares.
The RSUs will vest on the earlier of the first anniversary of the grant date or the day immediately before Cerence’s next fiscal year Annual General Meeting, aligning the director’s compensation with future company performance.
Cerence Inc. director Marcy S. Klevorn received an equity award of 12,968 shares of common stock at $0.01 per share on 02/12/2026. The award is reported as an acquisition and appears to represent restricted stock units that convert into common shares as they vest.
After this grant, Klevorn directly owns 35,404 shares of Cerence common stock. The RSUs will vest on the earlier of the first anniversary of the grant date or the day immediately before Cerence’s next fiscal-year annual general meeting, tying vesting to both time and the company’s shareholder meeting schedule.
Harris Marion reported acquisition or exercise transactions in this Form 4 filing.
Cerence Inc. director Marion Harris reported an equity award of 12,968 shares of common stock at $0.01 per share on February 12, 2026. This grant increased Harris’s directly held stake to 27,178 shares.
The award is structured as restricted stock units that will vest on the earlier of the first anniversary of the grant date or the day immediately before Cerence’s next fiscal year annual general meeting.
Cerence Inc. chief executive officer Brian M. Krzanich reported an equity award of 263,338 shares of common stock on January 9, 2026. The filing shows these shares at a reference price of $12.35 per share and indicates he beneficially owned 1,722,091 shares of Cerence common stock after this grant, held directly.
According to a footnote, the award is structured as restricted stock units under a Restricted Stock Unit Agreement. The units are scheduled to vest in three equal installments, with one-third of the shares vesting on each of October 1, 2026, October 1, 2027 and October 1, 2028, tying the compensation to continued service over that period.
Cerence Inc. reported that EVP and Chief Revenue Officer Christian Mentz received an award of 131,694 shares of common stock on January 9, 2026 at a price of $12.35 per share. The award is in the form of restricted stock units that vest in three equal parts on October 1, 2026, 2027, and 2028 under a Restricted Stock Unit Agreement. Following this grant, Mentz beneficially owns 293,474 shares of Cerence common stock in direct ownership.
Cerence Inc. executive Nils Schanz, EVP Product & Technology, reported receiving a grant of 87,796 shares of common stock on January 9, 2026. The filing describes this as a grant of restricted stock units under a Restricted Stock Unit Agreement at a reported price of $12.35 per share. According to the footnote, the shares vest in three equal installments, with one-third vesting on each of October 1, 2026, 2027, and 2028. After this grant, Schanz beneficially owns 342,682 shares of Cerence common stock, held directly.
Cerence Inc. executive Jennifer Salinas, EVP Chief Admin Officer, received a sizable equity award. On January 9, 2026, she was granted 131,694 shares of common stock at a price of $12.35 per share, reported as an acquisition of non-derivative securities.
The grant is described as restricted stock units under a Restricted Stock Unit Agreement, with the shares vesting in three equal installments on October 1, 2026, October 1, 2027, and October 1, 2028. Following this grant, Salinas beneficially owns 720,027 shares of Cerence common stock directly.
Cerence Inc. CFO Antonio Rodriquez reported an equity award on a Form 4. On January 9, 2026, he was granted 131,694 shares of Common Stock, reflecting restricted stock units with a reported value of $12.35 per share.
The footnote explains this is a grant of Restricted Stock Units under a Restricted Stock Unit Agreement. The RSUs vest in three equal installments, with one-third vesting on each of October 1, 2026, 2027, and 2028. After this grant, Rodriquez beneficially owned 575,246 shares of Cerence common stock, held directly.
Cerence Inc. (CRNC) reported an equity award to its Chief Executive Officer and director on a Form 4. On 11/21/2025, the executive acquired 552,766 shares of common stock at a price of $10.35 per share, classified as an acquisition transaction. Following this grant, the executive beneficially owns 1,458,753 shares of Cerence common stock in direct ownership.
The filing notes that this grant represents performance stock units (PSUs) achieved under the company’s FY25 plan, which are scheduled to vest in November 2027. This reflects a performance-based equity incentive aligning the CEO’s compensation with Cerence’s future results over the multi‑year performance period.
Cerence Inc. (CRNC) executive vice president and chief administrative officer reported acquiring 242,044 shares of common stock on 11/21/2025 at $10.35 per share. These shares reflect achieved performance stock units (PSUs) under the company’s fiscal 2025 plan that are scheduled to vest in November 2027.
Following this transaction, the officer beneficially owns 588,333 shares of Cerence common stock in direct ownership. The filing is made on Form 4 by a single reporting person and documents an equity-based compensation event rather than an open-market purchase.
Cerence Inc. (CRNC) reported an insider equity award for its CFO. On 11/21/2025, the chief financial officer acquired 166,821 shares of Cerence common stock at $10.35 per share, increasing beneficial ownership to 443,552 shares held directly. The filing explains that this grant represents achieved performance stock units under the FY25 plan, which are scheduled to vest in November 2027. This ties the executive’s compensation more closely to the company’s longer-term performance.
Cerence Inc. (CRNC) reported an equity award to its EVP and Chief Revenue Officer on a Form 4. On 11/21/2025, the executive acquired 49,905 shares of common stock at a price of $10.35 per share, reported as an acquired transaction. Following this award, the executive beneficially owns 161,780 shares of Cerence common stock in direct ownership.
The filing notes that this grant represents achieved performance stock units (PSUs) under the company’s FY25 plan, which are scheduled to vest in November 2027. This reflects part of the executive’s performance-based compensation structure tied to company goals over the fiscal 2025 period.
Cerence Inc. (CRNC) reported an equity transaction by its EVP, Product & Technology. On 11/21/2025, the executive acquired 49,905 shares of Cerence common stock at $10.35 per share. After this transaction, the executive beneficially owns 254,886 shares directly.
The company notes this grant represents performance stock units (PSUs) achieved under the FY25 plan that are scheduled to vest in November 2027, tying the award to longer-term performance and retention.